Tulane University

Tulane University, founded in 1834, is one of the most highly regarded and selective independent research universities in the United States. Tulane’s schools and colleges offer degrees in the liberal arts, science and engineering, architecture, business, law, social work, medicine, and public health and tropical medicine.


Dr. Cecilia Sanchez

We are working with Dr. Sanchez on RNA-Seq projects including mouse samples for lung fibrosis. Dr. Sanchez was born in Monterey, Calif., and grew up in Colombia. She earned her degree in microbiology from the University of Los Andes in Bogota. She obtained her DEA (MSc) Biology and Health at the University of Montpellier 2 in France. She went on to earn her Ph.D. degree in molecular genetics and molecular biology from the Louis Pasteur University in Strasbourg, working in the fields of nuclear receptors and epigenetics in the laboratory of Dr. Pierre Chambon at the IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire). She spent two years in post-doctoral training at Tulane University in the laboratory of Dr. Melanie Ehrlich, focusing on epigenetic studies in cancer. She had a second postdoctoral experience in the laboratory of Dr. Darwin Prockop, conducting studies in epigenetics and autophagy in stem cells with Dr. Pochampally. Dr. Sanchez was a recipient of the T-32 in Pulmonary diseases training grant in the laboratory of Dr. Lasky. She joined Tulane’s faculty as an Assistant Professor in May 2012. 2

  1.  “History.” Tulane University. Web. 17 Feb. 2016.
  2.  “Pulmonary Diseases, Critical Care, & Environmental Medicine.” Tulane University. Web. 17 Feb. 2016.


Cecilia Sanchez

Working with Pine Biotech has been an immense pleasure thanks to their willingness to provide great tutorials and a platform which allows us to truly understand how to best analyze our big data sets. We are certain as Pine Biotech continues to develop new algorithms for varied areas of analysis we will be able to find novel insights relevant to disease states in the future.